Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin L

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
Reply to topic
Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin L
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Thu Jun 05, 2008 8:22 am Reply with quote


SEATTLE----Seattle Genetics, Inc. today announced final data from the phase I clinical trial of SGN-40 in patients with relapsed or refractory non-Hodgkin lymphoma. SGN-40 is a humanized monoclonal antibody being developed under a worldwide collaboration agreement with Genentech, Inc.

Read more...
View user's profileSend private message
Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin L
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
 Reply to topic  
Forum Map
Site Map